About 7LK
7LK is a publicly listed company based in Guangzhou (China) founded in 2011. Non-prescription drugs and health supplements are retailed online by 7LK. 7LK has raised $48 million across 4 funding rounds from investors including JD.com, Orient Securities and ShenZhen GTJA Investment Group. Its focus areas include HealthTech, Healthcare Booking Platforms, Pharmacies and Drugs. Its competitors include 111 Group, Shanghai Pharmaceutical and Jingle fast medicine; 3 of its 3 listed competitors have raised funding.
Company details
7LK was founded in 2011 in Guangzhou, China, as an online retailer focused on non-prescription pharmaceuticals, medical devices, hygiene products, and contact lenses. Operations are integrated with the offline Guangzhou Qilekang Pharmaceutical Chain. Funding of 48M was raised in 2014 for warehouse and logistics development, while 100M Series B is allocated for expanding health consultation app services, including doctor searches and fee payments. Revenues exceeding 150M were reported in 2015.
- Headquarters Guangzhou, China
- Stage Public
- SectorsHealthcare
- Website 7lk.com
- Legal Name Pomdoctor Ltd. Unsponsored Adr
- Annual Revenue$55.63 M (USD)16.88as on Dec 31, 2025
- Net Profit-$29.57 M (USD)-48.46as on Dec 31, 2025
- EBITDA-$16.19 M (USD)-397.53as on Dec 31, 2025
- Total Equity Funding$48M (USD)
in 4 rounds
- InvestorsJD.com
& 9 more
Funding Insights of 7LK
7LK has successfully raised a total of $48M across 4 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $48M
- Total Rounds 4
- First Round $48M
(Jan 2015)
- Investors Count 10
All 4 funding rounds of 7LK with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2018 | Series B | – | ShenZhen GTJA Investment Group | – | |
| Feb 2017 | Series B | – | Share Capital, Orient Securities | – | |
| Jan 2016 | Series B | – | – | – | |
| Jan 2015 | $48M | Series A | – | Shanghai Changjiang Guohong Investment Management, Govtor | – |
10 investors in total: 10 institutional.
Investors in 7LK
7LK has secured backing from 10 investors, including venture fund and institutional investors. Prominent investors backing the company include JD.com, Orient Securities and ShenZhen GTJA Investment Group.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
| szgig.com | ||||
A venture capital firm based in Shenzhen, China, is operated. | sharecapital.cn | Shenzhen, China | ||
| greenwoodsinvest.com | ||||
Sequoia Capital is engaged in venture capital investments. | 1972 | sequoiacap.com | ||
| th-vc.com | ||||
Private equity investments are managed by the company. | 2012 | grandyangtze.com | Shanghai, China | |
A leading Chinese private equity and venture capital institution is operated. | govtor.com | Nanjing, China | ||
| tsinghua-vc.com | ||||
Integrated financial services are offered by Orient Securities in China. | 1998 | dfzq.com.cn | Shanghai, China | |
Multi-category consumer products are retailed online by JD.com. | 1998 | jd.com | Beijing, China |
Investor details for 7LK
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
IPO & Listings of 7LK
7LK is a publicly listed company on the NASDAQ with ticker symbol POM in USA, operating in the Distribution services sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date08 Oct 2025
- Listed onNASDAQ: POM
- Listed entityPomDoctor Ltd. Unsponsored ADR
- Exchange sectorDistribution services
- ISINUS73181R2076
- Share price$0.75 (+20.03% on the day) · 2026-10-13
- Market capitalisation$5.8M
- Volume (last session)165,927
Financials of 7LK
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | $55.6M | -$29.6M | -$16.2M |
| 2024 | $47.6M | -$19.9M | -$3.2M |
| 2023 | $43.0M | -$20.5M | -$2.9M |
| 2022 | $36.4M | -$18.6M | -$533,770 |
| 2021 | $33.4M | -$29.2M | -$5.2M |
Detailed financial statements for 7LK
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of 7LK
4 dated milestones of 7LK across 14 years, from founding to its latest funding, stage changes and deals.
- Founded 7LK is founded.
- Funding First funding round of $48.0M.
- Funding Latest funding round, Series B,.
- IPO Lists on the stock exchange (IPO).
Competitors of 7LK
7LK has 3 listed competitors in our database, 3 of them funded. They include 111 Group, Shanghai Pharmaceutical and Jingle fast medicine.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| 111.com.cn | 2010 | Guangzhou, China | $122M | Online pharmacy for selling pharmaceuticals and health products | ||
| sphcchina.com | 2015 | Shanghai, China | $228.18M | Provider of a cloud-based mobile app for purchasing medicines online | ||
| ddsy.com | 2014 | Beijing, China | $220M | O2O platform for medicines |
Detailed competitors of 7LK
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Web traffic of 7LK
The website of 7LK (7lk.com) receives about 1.7K visits a month.
- Monthly visits1.7K
▼ 3.9% vs previous month
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about 7Lk
Complete news archive for 7LK
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about 7LK
7LK was founded in 2011 and raised its 1st funding round 4 years after it was founded.
7LK is headquartered in Guangzhou, China. It is registered at Guangzhou, Guangdong, China.
7LK is a funded company, having raised a total of $48M across 4 funding rounds to date. The company's 1st funding round was a Series A of $48M, raised on Jan 2015.
Annual revenue of 7LK is $55.63M as on Dec 31, 2025.
7LK was founded in 2011 in Guangzhou, China, as an online retailer focused on non-prescription pharmaceuticals, medical devices, hygiene products, and contact lenses. Operations are integrated with the offline Guangzhou Qilekang Pharmaceutical Chain. Funding of 48M was raised in 2014 for warehouse and logistics development, while 100M Series B is allocated for expanding health consultation app services, including doctor searches and fee payments. Revenues exceeding 150M were reported in 2015.
7LK's top competitors include 111 Group, Shanghai Pharmaceutical and Jingle fast medicine.
Yes, 7LK is publicly traded on NASDAQ under the ticker symbol POM.
7LK has 10 investors. Key investors include JD.com, Orient Securities, ShenZhen GTJA Investment Group, Share Capital, and Greenwoods Investments.